Programmed Cell Death-Ligand 1 (PD-L1) in Mismatch Repair Protein Deficient Colon Cancer: An Immunohistochemical and Genomic Profiling Study

被引：0
|
作者：
Lee, Hwajeong
Geiersbach, Katherine
Ainechi, Sanaz
Sheehan, Christine E.
Jones, David M.
Affoltez, Kajsa
Bronnez, Mary P.
Ross, Jeffrey S.
机构：
[1] Albany Med Ctr, Albany, NY USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
716
引用
收藏
页码：181A / 181A
页数：1
相关论文
共 50 条
  • [1] Programmed Cell Death-Ligand 1 (PD-L1) in Mismatch Repair Protein Deficient Colon Cancer: An Immunohistochemical and Genomic Profiling Study
    Lee, Hwajeong
    Geiersbach, Katherine
    Ainechi, Sanaz
    Sheehan, Christine E.
    Jones, David M.
    Affolter, Kajsa
    Bronner, Mary P.
    Ross, Jeffrey S.
    LABORATORY INVESTIGATION, 2016, 96 : 181A - 181A
  • [2] Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer
    Govindarajan, Rangaswamy
    Gujja, Swetha
    Siegel, Eric R.
    Batra, Anu
    Saeed, Anwaar
    Lai, Keith
    James, Jennifer D.
    Fogel, Bradley J.
    Williamson, Stephen
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (07): : 638 - 642
  • [3] Programmed Cell Death-Ligand 1 (PD-L1) Immunohistochemical Expression in Equine Melanocytic Tumors
    Pimenta, Jose
    Prada, Justina
    Pires, Isabel
    Cotovio, Mario
    ANIMALS, 2024, 14 (01):
  • [4] Evaluation of Programmed Death-Ligand 1 (PD-L1) Immunohistochemical Expression in Cytology Cell Block Preparations
    Hernandez, A.
    Brandler, T. C.
    Moreira, A.
    Schatz-Siemers, N.
    Simsir, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN PHEOCHROMOCYTOMA
    Hashimoto, Yasuhiro
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Koie, Takuya
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2017, 197 (04): : E474 - E474
  • [6] Induction Mechanism of PD-L1 (Programmed Cell Death-ligand 1) in Sepsis
    Lee, Sang-Min
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2008, 65 (04) : 343 - 350
  • [7] Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer
    Nunez Abad, Martin
    Calabuig-Farinas, Silvia
    Lobo de Mena, Miriam
    Torres-Martinez, Susana
    Garcia Gonzalez, Clara
    Garcia Garcia, Jose Angel
    Iranzo Gonzalez-Cruz, Vega
    Camps Herrero, Carlos
    CANCERS, 2022, 14 (02)
  • [8] Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer
    Bari, Shahla
    Muzaffar, Jameel
    Chan, Austin
    Jain, Sanjay R.
    Haider, Ahmad M.
    Curry, Marjorie Adams
    Hostler, Christopher J.
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [9] In Reply: Programmed Death-Ligand 1 (PD-L1) Immunohistochemistry Calibration
    Sompuram, Seshi R.
    Torlakovic, Emina E.
    t' Hart, Nils A.
    Vani, Kodela
    Bogen, Steven A.
    MODERN PATHOLOGY, 2023, 36 (02)
  • [10] Programmed death-ligand 1 (PD-L1) expression in pheochromocytoma.
    Hashimoto, Yasuhiro
    Yamamoto, Hayato
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345